Complications And Recurrence Of Nodular Fasciitis After Treatment
Published on: March 10, 2025
Complications And Recurrence Of Nodular Fasciitis After Treatment
Article author photo

Hanan Fawzy Abdelmaksod Aly

Bachelor of Pharmacy, MBA in Global Management

Article reviewer photo

Dr. Halimat Issa

MB;BS (2024)

Introduction

Nodular fasciitis is a benign soft tissue lesion that grows quickly. Owing to its high cellularity and quick growth, it occasionally receives the incorrect diagnosis of a malignant tumor. Even though it is not malignant and usually goes away on its own, therapy may occasionally be required. Especially when symptoms or cosmetic concerns arise, understanding the potential complications and recurrence of nodular fasciitis after treatment is essential for patients and healthcare professionals.1

Overview of nodular fasciitis

A reactive proliferation of fibroblasts, nodular fasciitis usually originates in the muscles, fascia, or subcutaneous tissues (the layer just beneath the skin). Because of its aggressive development pattern, it often manifests as a small, rapidly expanding tumor that is mistaken for sarcoma. Although it can occur at any age, young individuals are the most common target of this lesion. Histologically, plump spindle cells, a myxoid stroma, and a rapid mitotic rate are characteristics of nodular fasciitis that might cause a false positive for a malignant tumor.2

Importance of understanding complications and recurrence post-treatment

Understanding side effects and recurrence after therapy is crucial. Patients and healthcare providers must be cognizant of the potential for problems and recurrence during nodular fasciitis treatment. 

Complications can arise with cryotherapy, the injection of corticosteroids, and surgical excisions. Furthermore, the lesion has a high probability of returning, particularly following surgical therapy.

We can improve treatment plans to lower risks, improve outcomes, and better prepare patients by looking closely at these issues.3

Common presentations and symptoms

One of the most common ways that nodular fasciitis appears is as a single, quickly expanding, hard, and occasionally painful lump. Though it can happen anywhere in the body, the upper extremities, especially the forearm, are where it most usually appears first, then the trunk, and finally the neck area.

Patients notice the lesion as a small pumb that can grow noticeably within a few weeks. Pain and tenderness are common, particularly if the lesion is located near a nerve or sensitive structure. However, some individuals may have nodular fasciitis without significant discomfort.

Epidemiology and demographic

Men and women are nearly equally affected by nodular fasciitis; however, it typically affects young adults in the 20–40 age group. There is no obvious gender preference.  Some researchers conclude that nodular fasciitis could result from a little trauma or injury, although this is not always the case. But it is unclear exactly where the illness originated. The condition doesn’t show any particular racial or ethnic tendency; it is equally common in all populations.4 

Diagnosis of nodular fasciitis

The diagnosis procedure makes use of a mix of clinical examination, imaging technologies, and histological analysis to accurately identify and differentiate nodular fasciitis from other disorders.

Clinical examination

A healthcare practitioner will first perform a thorough clinical examination and document the size, location, and growth rate of the lesion. A rapidly growing, hard, and sometimes painful mass beneath the skin is nodular fasciitis's typical appearance. Despite its potential for rapid growth, one important finding from the inspection is that the lesion is not malignant.

Imaging techniques (MRI & ultrasound)

Two imaging modalities are used to assess the lesion further: MRI and ultrasonography. The mass’s composition can be ascertained with ultrasound by differentiating between its solid and systic components.  Because of its advanced imaging capabilities, MRI provides a clear picture of the lesion’s size, location, and relationship to the surrounding tissues. MRI is a valuable tool for identifying nodular fasciitis by showing its unique features, such as uniform enhancement and well-defined borders, which can help differentiate the condition from malignant tumors.5

Histopathological findings

Under a microscope, histological analysis of a biopsy sample is frequently used to reach a conclusive diagnosis. Fibroblast and myofibroblast growth are seen in nodular fasciitis, where they are organized in a loose, feathery style. Nodular fasciitis is indicated by the presence of these cells in conjunction with a myxoide (gel-like) backdrop and sporadic inflammatory cells. These results are essential for verifying that the lesion is benign.6 

Differential diagnosis

A differential diagnosis is essential because nodular fasciitis can resemble more severe conditions. Diseases, including fibromatosis, soft tissue sarcomas, and other benign fibrous growths, must be considered. The histological features and rapid progression of nodular fasciitis help to distinguish it from several other conditions. If the lesion is mistakenly identified as a malignant tumor, drastic treatments are avoided.7

Treatment options for nodular fasciitis

Treatment options may vary according to the size, location, or self-healing of the lesion. Below are the most feasible treatment methods: 

Observation and natural regression

Given its self-limiting nature, many cases of nodular fasciitis resolve without intervention. Observation is often recommended, especially if the lesion is asymptomatic and not causing any functional impairment.8

Surgical excision

Surgical excision is the most common treatment option for troublesome or unattractive lesions. The lesion must be excised while leaving a margin of healthy tissue. 

Corticosteroid injections

In some cases, corticosteroid injections intravenously can reduce inflammation and promote lesion remission.

Cryotherapy

Freezing the lesion can cause a progressive decrease in its size and growth.

Complications of nodular fasciitis treatment

Although nodular fasciitis is usually benign, treatment for it can have unintended consequences. These side effects can be divided into groups based on whether they were treated non-surgically or with surgery.9

Surgical complications

  1. infection

There is a chance of infection with any surgical operation. Postoperative infections can take a variety of forms, ranging from mild surface infections to more severe deep tissue infections. Adequate surgical technique and subsequent care are essential to lowering this risk.

  1. Scarring

From a cosmetic perspective, scarring following surgical excision might not be optimal, especially if the scar is obviously noticed by the patient and surrounding people.

  1. Recurrence

The possibility of recurrence is one of the biggest worries with surgical treatment. Nodular fasciitis may recur if the lesion is not completely removed and some of it remains. Preventing this problem during surgery requires making sure that the margins are clear.

  1. Nerve damage

Surgical excision may be risky for surrounding nerves, depending on the lesion’s location. This could result in either acute or chronic nerve damage, as well as related sensory or motor abnormalities.

Non-surgical complications

  1. Steroid side effects

Injections of corticosteroids can be beneficial, but they can also have unfavorable consequences, such as skin thinning, localized infections, and systemic effects when they enter the bloodstream.

  1. Incomplete regression

Non-surgical treatments could not always completely resolve the lesion, which could result in ongoing symptoms or the requirement for more care.

Recurrence of nodular fasciitis after treatment

One significant issue is the recurrence of nodular fasciitis following treatment, especially surgical excision. Recurrence rates differ; some studies indicate that in some circumstances, they may be as high as 15-20%. Several factors can influence the likelihood of recurrence.10

Factors influencing recurrence rate

Incomplete excision

Incomplete lesion excision during surgery is the main cause of recurrence. This may occur if satellite nodules are overlooked or if the lesion is not completely removed.

Anatomical location of the lesion

Lesions located in areas where complete excision is challenging, such as near critical structures or within deep tissues, are more likely to recur.

Biological behavior of the lesion

While nodular fasciitis is benign, its aggressive growth pattern can sometimes mimic more malignant behavior, leading to recurrence even after seemingly complete excision.

Strategies to minimize recurrence11

Various tactics can be used to lower the recurrence incidence, including the following: 

Importance of thorough surgical techniques

During surgical excision, it is critical to have clear margins. To lessen the possibility of residual suspected tissues, surgeons should try to remove the lesion with a margin of normal tissue.

Pre-operative planning with imaging

A precise imaging examination can be used to help define the lesion’s extent and direct surgical planning. When determining the extent and limits of nodular fasciitis, magnetic resonance imaging (MRI) is especially helpful.

Post-operative monitoring and follow-up

It is crucial to schedule follow-up sessions on a regular basis to look for recurrence symptoms. Early regrowth diagnosis enables timely intervention, which may lessen the amount of therapy that is necessary.  

Role of adjuvant therapy (corticosteroid & cryotherapy)

In cases where complete excision is not feasible or recurrence is likely. Adjuvant therapies such as corticosteroid injections or cryotherapy may be considered to supplement surgical treatment.

Management strategies for recurrent nodular fasciitis include

Repeat surgical excision

If recurrence is localized and accessible, repeat surgical excision may be recommended to remove the regrown tumor growth and surrounding affected tissues  

Radiation therapy

In cases where surgical excision is challenging or associated with high risk, radiation therapy may be considered to control tumor growth and alleviate symptoms.

Emerging therapies

Investigational approaches such as targeted therapies and immunomodulators are being explored for nodular fasciitis resistant to standard treatments. These therapies aim to provide alternative options for managing recurrent or refractory cases.

Case studies and clinical evidence12

Several studies have investigated the outcomes of different treatment modalities for nodular fasciitis, providing valuable insights into recurrence rates and complications.

Study 1: Retrospective reviews and their findings

A retrospective review of 100 cases of nodular fasciitis treated with surgical excision reported a recurrence rate of 10%. Factors associated with recurrence included incomplete excisions and deep tissue involvement.

Study 2: Studies on different treatment outcomes 

Another study looked at 50 patients with nodular fasciitis who received corticosteroid injections. Although lesion size decreased significantly in 80% of patients, 10% of patients needed additional treatments because their regression was not complete.

Study 3: Studies on the outcomes of cryotherapy

According to a study on nodular cryotherapy results, 85% of patients experienced total recovery and a 5% recurrence rate. On the other hand, some patients encountered adverse consequences such as skin blistering and changes in pigmentation.  

Patient experience and quality of life

Living with a fast-expanding mass, going through treatment, and worrying about a recurrence can have a big psychological impact. To resolve issues, control expectations, and guarantee the best possible care, open communication between patients and healthcare professionals is crucial. Managing diagnosis and course of therapy. 

The psychological impact of diagnosis and treatment (emotional support)

When a patient is diagnosed with nodular fasciitis, the initial suspicion of cancer frequently causes anxiety and dread. Some of this worry can be reduced by offering assurances regarding the benign nature of the ailment and by going over possible treatment choices. 

Pain management strategies

Effective pain management techniques are crucial to ensuring comfort throughout the recovery phase for patients having surgical excisions. This could entail prescription drugs, physical treatment, and assistance.

Addressing cosmetic concerns

Given the potential for scarring and visible changes, addressing cosmetic concerns is vital. Discussing reconstructive options and involving a plastic surgeon when necessary can help achieve better cosmetic outcomes.

Long-term monitoring and recurrence management

Importance of regular check-ups

Making routine follow-up appointments makes it possible to identify recurrences early on. It is important to teach patients how to do self-examination and to report any changes right away.

Lifestyle adjustments to support recovery

Promoting a healthy lifestyle that includes stress reduction and a balanced diet can help with healing and general well-being.

Connecting patients with support groups 

Overall well-being and recovery can be aided by promoting a healthy lifestyle that includes stress management and a balanced diet.

FAQs

Does nodular fasciitis recur?

Nodular fasciitis is completely benign. The tumor could disappear over time or be removed through surgery. It is extremely unlikely to come back. This mass does not develop into cancer or increase your cancer risk.

Can nodular fasciitis become malignant?

Nodular fasciitis is a benign fibroblast, self-limited, it might be misdiagnosed as a malignant tumor.

What is the epidemiology of nodular fasciitis?

The most common epidemiology is in individuals between the ages of 20 and 40, but children are also affected.

What is the clinical presentation of nodular fasciitis?

It is a fibrous growth that usually affects subcutaneous tissue. All age groups experience it, but young adults experience it most frequently. Any part of the body can be impacted; however, the upper extremities, trunk, head and neck (including the salivary glands)

Summary

Despite being benign, nodular fasciitis has special problems in terms of treatment consequences and recurrence. The cornerstone of treatment is still surgical excision, but to reduce risks, technique and post-operative care must be carefully considered.

Alternative methods are provided by non-surgical treatments, including cryotherapy and corticosteroid injections, although they have their own set of possible drawbacks.

Improved patient outcomes can result from an understanding of the factors that influence recurrence and the implementation of methods to avoid these risks. In the end, controlling nodular fasciitis and guaranteeing a high quality of life for individuals afflicted require a patient-centered strategy that places a high priority on clear communication, emotional support, and comprehensive follow-up care.

Close observation and suitable postoperative care are crucial to avoid these issues and encourage the best possible recovery.

References

  1. Allison DB, Wakely PE, Siddiqui MT, Ali SZ. Nodular fasciitis: A frequent diagnostic pitfall on fine‐needle aspiration. Cancer Cytopathology [Internet]. 2016 Aug 15;125(1):20–9. Available from: https://doi.org/10.1002/cncy.21768
  2. Moore DW MD. Nodular fasciitis - pathology - orthobullets [Internet]. Available from: https://www.orthobullets.com/pathology/8063/nodular-fasciitis
  3. Hüter E, Lee C, Sherry R, Udey M. Spontaneous regression and recurrence in a case of nodular fasciitis. Acta Dermato Venereologica [Internet]. 2009 Jan 1;89(4):438–9. Available from: https://doi.org/10.2340/00015555-0664
  4. Baki AM, Ramli R, Noor RM, Mohamad I, Jais M. Nodular fasciitis of the posterior ethmoid sinus: uncommon tumour at uncommon sites. Medeniyet Medical Journal [Internet]. 2020 Jan 1; Available from: https://doi.org/10.5222/mmj.2020.90093
  5. Zhuang N, Lyu H, Zhao C, Zhang Y, Dong L, Luo H, et al. Ultrasound features and differential diagnosis for superficial nodular fasciitis. Journal of Clinical Ultrasound [Internet]. 2023 Aug 21;51(8):1370–5. Available from: https://doi.org/10.1002/jcu.23542
  6. Al-Hayder S, Warnecke M, Hesselfeldt-Nielsen J. Nodular fasciitis of the face: A case report. International Journal of Surgery Case Reports [Internet]. 2019 Jan 1;61:207–9. Available from: https://www.sciencedirect.com/science/article/pii/S2210261219303839
  7. Luna A, Molinari L, Garlatti L a. B, Ferrario D, Volonteri V, Roitman P, et al. Nodular fasciitis, a forgotten entity. International Journal of Dermatology [Internet]. 2018 Sep 6;58(2):190–3. Available from: https://doi.org/10.1111/ijd.14219
  8. Hakobyan G, Pogosyan A, Hakobyan G, Hovhannisyan M, Misakyan M, Burnazyan S. Treatment of nodular fasciitis on the front surface of the neck. Dental Oral Biology and Craniofacial Research [Internet]. 2020 Feb 19;1–4. Available from: https://www.sciencerepository.org/treatment-of-nodular-fasciitis_DOBCR-2020-1-103
  9. Oh BH, Kim J, Zheng Z, Roh MR, Chung KY. Treatment of nodular fasciitis occurring on the face. Annals of Dermatology [Internet]. 2015 Jan 1;27(6):694. Available from: https://doi.org/10.5021/ad.2015.27.6.694
  10. Hüter E, Lee C, Sherry R, Udey M. Spontaneous regression and recurrence in a case of nodular fasciitis. Acta Dermato Venereologica [Internet]. 2009 Jan 1;89(4):438–9. Available from: https://doi.org/10.2340/00015555-0664
  11. Morris BS. Nodular Fasciitis: A Surprisingly Common But Underrecognized Cause of the Solitary Subcutaneous Nodule [Internet]. Vol. 15, Proceedings of UCLA Healthcare. 2011. Available from: https://www.proceedings.med.ucla.edu/wp-content/uploads/2017/01/Nodular-Fasciitis.pdf
  12. Meister P, Bückmann F w., Konrad E. Nodular fasciitis (Analysis of 100 cases and review of the literature). Pathology - Research and Practice [Internet]. 1978 Jul 1;162(2):133–65. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0344033878800016

Share

Hanan Fawzy Abdelmaksod Aly

Bachelor of Pharmacy, MBA in Global Management

Dr. Hanan Fawzy is a seasoned pharmaceutical plant manager with a strong background in managing and operating both sterile I.V. parenteral and non-sterile pharmaceutical products.

Holding a Bachelor of Pharmacy and an MBA in Global Management from ESLSCA Business School, Dr. Fawzy brings a wealth of expertise to the pharmaceutical industry. Passionate about medical and pharmaceutical research, Dr. Fawzy excels in translating complex scientific literature into easily understandable language for the general public.

arrow-right